Introduction: Iodothyronine deiodinases are selenoproteins with the amino acid selenocysteine (Sec) introduced into the position of a TGA stop codon by a complex machinery involving tRNA[Ser]Sec when a cis-acting Sec-insertion sequence element is present in the 3′ end of the mRNA. Recently, a variant in the TRU-TCA1-1 gene encoding for tRNA[Ser]Sec was reported, which resulted in reduced expression of stress-related selenoproteins. The proband presented with multisystem symptoms, euthyroid hyperthyroxinemia, and selenium deficiency. Here, we describe 2 new members of a family harboring the same tRNA[Ser]Sec variant. Case Presentation: A 13-year-old patient was seen for Hashimoto’s disease with high FT3 (4.6 pg/mL, normal range 2–4.2 pg/mL) and normal FT4 and TSH concentrations. He had no clinical complaints. During a 6-year clinical and hormonal follow-up, the index patient was not treated, FT3 decreased, FT4 increased, and serum TSH stayed in the normal range resulting in a euthyroid hyperthyroxinemia. Reverse T3 concentration was significantly increased at the last visit (19 years and 4 months). At the last evaluation, the total selenium level was low (91 μg/L, normal range 95–125). DNA sequencing identified a germinal homozygous variant (C65G) in the TRU-TCA1-1 gene. During follow-up, no additional clinical symptom was observed in the absence of any treatment. The same germinal tRNA[Ser]Sec variant was identified at heterozygous state in his father, who had normal thyroid function tests except a moderately increased reverse T3 concentration, with increased total selenium (143 μg/L) level. In both patients, the expression of stress-related selenoprotein GPX3 was in the low-normal range (168 and 180 IU/L, respectively, normal range: 150–558 IU/L). We did not find any significant biological abnormalities evocative of other selenoprotein deficiencies. Discussion/Conclusion: We report on 2 members of a family with a variant in the TRU-TCA1-1 gene encoding for tRNA[Ser]Sec. Our study suggests that this tRNA[Ser]Sec variant is not exclusively causative of disruption in selenoprotein synthesis.

1.
Arthur
JR
,
Bermano
G
,
Mitchell
JH
,
Hesketh
JE
.
Regulation of selenoprotein gene expression and thyroid hormone metabolism
.
Biochem Soc Trans
.
1996 May
;
24
(
2
):
384
8
. .
2.
Drutel
A
,
Archambeaud
F
,
Caron
P
.
Selenium and the thyroid gland: more good news for clinicians
.
Clin Endocrinol
.
2013 Feb
;
78
(
2
):
155
64
.
3.
Shetty
SP
,
Copeland
PR
.
Selenocysteine incorporation: a trump card in the game of mRNA decay
.
Biochimie
.
2015 Jul
;
114
:
97
101
. .
4.
Labunskyy
VM
,
Hatfield
DL
,
Gladyshev
VN
.
Selenoproteins: molecular pathways and physiological roles
.
Physiol Rev
.
2014 Jul
;
94
(
3
):
739
77
. .
5.
Schoenmakers
E
,
Carlson
B
,
Agostini
M
,
Moran
C
,
Rajanayagam
O
,
Bochukova
E
,
Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesis
.
J Clin Invest
.
2016 Mar
;
126
(
3
):
992
6
. .
6.
Schoenmakers
E
,
Agostini
M
,
Mitchell
C
,
Schoenmakers
N
,
Papp
L
,
Rajanayagam
O
,
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans
.
J Clin Invest
.
2010 Dec
;
120
(
12
):
4220
35
. .
7.
Fradejas-Villar
N
.
Consequences of mutations and inborn errors of selenoprotein biosynthesis and functions
.
Free Radic Biol Med
.
2018 Nov
;
127
:
206
14
. .
8.
Di Cosmo
C
,
McLellan
N
,
Liao
XH
,
Khanna
KK
,
Weiss
RE
,
Papp
L
,
Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X)
.
J Clin Endocrinol Metab
.
2009 Oct
;
94
(
10
):
4003
9
. .
9.
Schomburg
L
,
Dumitrescu
AM
,
Liao
XH
,
Bin-Abbas
B
,
Hoeflich
J
,
Köhrle
J
,
Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations
.
Thyroid
.
2009 Mar
;
19
(
3
):
277
81
. .
10.
Kim
LK
,
Matsufuji
T
,
Matsufuji
S
,
Carlson
BA
,
Kim
SS
,
Hatfield
DL
,
Methylation of the ribosyl moiety at position 34 of selenocysteine tRNA[Ser]Sec is governed by both primary and tertiary structure
.
RNA
.
2000 Sep
;
6
(
9
):
1306
15
. .
11.
Kim
JY
,
Carlson
BA
,
Xu
XM
,
Zeng
Y
,
Chen
S
,
Gladyshev
VN
,
Inhibition of selenocysteine tRNA[Ser]Sec aminoacylation provides evidence that aminoacylation is required for regulatory methylation of this tRNA
.
Biochem Biophys Res Commun
.
2011 Jun
;
409
(
4
):
814
9
. .
12.
Hatfield
D
,
Lee
BJ
,
Hampton
L
,
Diamond
AM
.
Selenium induces changes in the selenocysteine tRNA[Ser]Sec population in mammalian cells
.
Nucleic Acids Res
.
1991 Feb
;
19
(
4
):
939
43
. .
13.
Diamond
AM
,
Choi
IS
,
Crain
PF
,
Hashizume
T
,
Pomerantz
SC
,
Cruz
R
,
Dietary selenium affects methylation of the wobble nucleoside in the anticodon of selenocysteine tRNA([Ser]Sec)
.
J Biol Chem
.
1993 Jul
;
268
(
19
):
14215
23
. .
14.
Schoenmakers
E
,
Chatterjee
K
.
Identification of genetic disorders causing disruption of selenoprotein biosynthesis
.
Methods Mol Biol
.
2018
;
1661
:
325
35
. .
15.
Peskin
AV
,
Winterbourn
CC
.
A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1)
.
Clin Chim Acta
.
2000 Mar
;
293
(
1–2
):
157
66
. .
16.
Dumitrescu
AM
,
Liao
XH
,
Abdullah
MS
,
Lado-Abeal
J
,
Majed
FA
,
Moeller
LC
,
Mutations in SECISBP2 result in abnormal thyroid hormone metabolism
.
Nat Genet
.
2005 Nov
;
37
(
11
):
1247
52
. .
17.
Germain
DL
,
Hernandez
A
,
Schneider
MJ
,
Galton
VA
.
Insights into the role of deiodinases from studies of genetically modified animals
.
Thyroid
.
2005 Aug
;
15
(
8
):
905
16
. .
18.
Taylor
PN
,
Sayers
A
,
Okosieme
O
,
Das
G
,
Draman
MS
,
Tabasum
A
,
Maturation in serum thyroid function parameters over childhood and puberty: results of a Longitudinal Study
.
J Clin Endocrinol Metab
.
2017 Jul
;
102
(
7
):
2508
15
. .
19.
Marwaha
RK
,
Tandon
N
,
Desai
AK
,
Kanwar
R
,
Sastry
A
,
Narang
A
,
The evolution of thyroid function with puberty
.
Clin Endocrinol
.
2012 Jun
;
76
(
6
):
899
904
. .
20.
Tobe
R
,
Mihara
H
.
Delivery of selenium to selenophosphate synthetase for selenoprotein biosynthesis
.
Biochim Biophys Acta Gen Subj
.
2018 Jun
;
1862
(
18
):
2433
40
. .
21.
Zhu
K
,
Jiang
L
,
Chu
Y
,
Zhang
YS
.
Protective effect of selenium against cisplatin-induced nasopharyngeal cancer in male albino rats
.
Oncol Lett
.
2016 Dec
;
12
(
6
):
5068
74
. .
22.
Woo
HA
,
Yim
SH
,
Shin
DH
,
Kang
D
,
Yu
DY
,
Rhee
SG
.
Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling
.
Cell
.
2010 Feb 19
;
140
(
4
):
517
28
. .
23.
Méplan
C
.
Association of single nucleotide polymorphisms in selenoprotein genes with cancer risk
.
Methods Mol Biol
.
2018
;
1661
:
313
24
. .
24.
Guo
L
,
Yang
W
,
Huang
Q
,
Qiang
J
,
Hart
JR
,
Wang
W
,
Selenocysteine-specific mass spectrometry reveals tissue-distinct selenoproteomes and candidate selenoproteins
.
Cell Chem Biol
.
2018 Nov
;
25
(
11
):
1380
8.e4
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.